Gross & Hartman Investments’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$319K Buy
266
+2
+0.8% +$2.04K 0.14% 54
2026
Q1
$243K Sell
264
-6
-2% -$6.08K 0.13% 64
2025
Q4
$290K Buy
+270
New +$258K 0.17% 54

Other funds holding LLY

Gross & Hartman Investments's LLY Position: Q2 2026 in Review

Gross & Hartman Investments increased its Eli Lilly (LLY) stake by 0.76% in Q2 2026, buying an estimated $2.04K and bringing the position to 266 shares worth $319K. The position accounts for 0.14% of the portfolio, ranked #54.

Gross & Hartman Investments first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 4,431 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Gross & Hartman Investments held 266 shares of Eli Lilly worth $319K as of Q2 2026.
  • Gross & Hartman Investments bought 2 Eli Lilly shares in Q2 2026, an estimated $2.04K.
  • Eli Lilly made up 0.14% of Gross & Hartman Investments's portfolio in Q2 2026, its #54 holding.
  • Gross & Hartman Investments first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • 4,431 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Gross & Hartman Investments's 13F filing for Q2 2026, filed 13 Aug 2026.